Long-term clinical outcomes of vasodilating beta-blockers in acute myocardial infarction patients with preserved left ventricular ejection fraction after a successful stent implantation

9 May 2026 (08:00 - 12:45)

Organised by:

Sign in to view the resources

About the speaker

Mr Doyoon Lee

Jeju (Korea (Republic of))

5 More presentations in this session

Presentation thumbnail

Current clinical use of edoxaban 15 mg in hospitalized patients with heart failure: analysis from the JROAD-DPC database

Doctor Y. Fujimoto (Tokyo, JP)

Abstract Slides

Presentation thumbnail

Anticoagulants and pulmonary embolism: the surprising impact of apixaban on bilateral embolism

Doctor R. Brandao (Amadora, PT)

Presentation thumbnail

Pulmonary Embolism in anticoagulated patients: a retrospective single-centered cohort comparing data from the PIOPED II study

Doctor R. Brandao (Amadora, PT)

Presentation thumbnail

Nonuse of oral anticoagulation and outcomes across the ejection-fraction spectrum in acute heart failure with atrial fibrillation

Doctor J. Yamamoto (Tokyo, JP)

Presentation thumbnail

Cardiac adverse event profiles of EGFR tyrosine kinase inhibitors: a disproportionality analysis using eudravigilance

Doctor Y. Shhab (Bucharest, RO)

Access the full session

Session thumbnail

ePosters in pharmacology and pharmacotherapy (1)

The Event

Event poster

Heart Failure 2026

9 May - 12 May 2026

You may be interested in

Webinar

Are beta-blockers still indicated after myocardial infarction?

Congress Presentation

Impact of beta-blocker therapy in patients with preserved left ventricular ejection fraction after ST-segment elevation myocardial infarction

Congress Presentation

Betablockers post-acute myocardial infarction

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources